Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation.

VE-cadherin cadherin endothelial barrier restoration endothelial cell endothelial dysfunction lipid signaling phosphatidic acid signaling phospholipase D2 (PLD2) phosphotyrosine signaling protein tyrosine phosphatase non-receptor type 14 (PTPN14)

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
29 05 2020
Historique:
received: 11 11 2019
revised: 03 04 2020
pubmed: 25 4 2020
medline: 29 12 2020
entrez: 25 4 2020
Statut: ppublish

Résumé

Increased permeability of vascular lung tissues is a hallmark of acute lung injury and is often caused by edemagenic insults resulting in inflammation. Vascular endothelial (VE)-cadherin undergoes internalization in response to inflammatory stimuli and is recycled at cell adhesion junctions during endothelial barrier re-establishment. Here, we hypothesized that phospholipase D (PLD)-generated phosphatidic acid (PA) signaling regulates VE-cadherin recycling and promotes endothelial barrier recovery by dephosphorylating VE-cadherin. Genetic deletion of

Identifiants

pubmed: 32327488
pii: S0021-9258(17)49458-0
doi: 10.1074/jbc.RA119.011801
pmc: PMC7261798
doi:

Substances chimiques

Antigens, CD 0
Cadherins 0
cadherin 5 0
PTPN14 protein, human EC 3.1.3.48
PTPN14 protein, mouse EC 3.1.3.48
Protein Tyrosine Phosphatases, Non-Receptor EC 3.1.3.48
phospholipase D2 EC 3.1.4.-
Phospholipase D EC 3.1.4.4
Thrombin EC 3.4.21.5

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7669-7685

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL060678
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR075830
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA053840
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007829
Pays : United States

Informations de copyright

© 2020 Fu et al.

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

Biochim Biophys Acta. 2009 Sep;1791(9):856-61
pubmed: 19422932
Dev Cell. 2013 Sep 16;26(5):441-54
pubmed: 24044891
J Lipid Res. 2015 Dec;56(12):2229-37
pubmed: 25926691
Biochim Biophys Acta. 2009 Jul;1793(7):1236-49
pubmed: 19371764
Chem Biol Interact. 2008 Jan 30;171(2):177-89
pubmed: 17897637
J Biol Chem. 2014 Aug 22;289(34):23693-700
pubmed: 25023289
Blood. 1992 Apr 15;79(8):2056-67
pubmed: 1314112
Dev Cell. 2017 Oct 23;43(2):186-197.e7
pubmed: 29033361
PLoS One. 2013 May 08;8(5):e63007
pubmed: 23667561
J Cell Sci. 2008 Jul 1;121(Pt 13):2115-22
pubmed: 18565824
Curr Opin Cell Biol. 2010 Oct;22(5):651-8
pubmed: 20708398
J Exp Med. 2014 Mar 10;211(3):579-91
pubmed: 24590762
Am J Hum Genet. 2010 Sep 10;87(3):436-44
pubmed: 20826270
J Cell Biol. 2019 May 6;218(5):1725-1742
pubmed: 30948425
Am J Pathol. 2005 Apr;166(4):1247-58
pubmed: 15793303
Nat Cell Biol. 2006 Nov;8(11):1223-34
pubmed: 17060906
Mol Biol Cell. 2003 Jun;14(6):2520-9
pubmed: 12808048
Pulm Circ. 2013 Jan;3(1):108-15
pubmed: 23662182
J Lipid Res. 2012 Dec;53(12):2598-609
pubmed: 22991193
Acta Biochim Pol. 2018;65(2):163-171
pubmed: 29913482
Nat Cell Biol. 2008 Aug;10(8):883-5
pubmed: 18670447
J Biol Chem. 2016 Dec 30;291(53):27187-27203
pubmed: 27864331
Biochem Soc Trans. 2003 Feb;31(Pt 1):94-7
pubmed: 12546662
Mediators Inflamm. 2015;2015:272858
pubmed: 26556953
Biochem J. 2002 Nov 1;367(Pt 3):751-60
pubmed: 12149127
Mediators Inflamm. 2016;2016:8696481
pubmed: 28119542
Nat Commun. 2012 Jan 10;3:616
pubmed: 22233626
J Clin Invest. 2012 Aug;122(8):2731-40
pubmed: 22850883
J Exp Med. 2015 Dec 14;212(13):2267-87
pubmed: 26642851
N Engl J Med. 2010 Aug 12;363(7):689-91
pubmed: 20818861
Genes Dev. 2012 Sep 1;26(17):1959-71
pubmed: 22948661
J Biol Chem. 2016 Sep 23;291(39):20729-38
pubmed: 27510034
Am J Physiol Lung Cell Mol Physiol. 2019 Aug 1;317(2):L175-L187
pubmed: 31090437
J Physiol. 2005 Dec 1;569(Pt 2):359-66
pubmed: 16195317
Trends Plant Sci. 2013 Sep;18(9):496-504
pubmed: 23664415
Histochem Cell Biol. 2008 Jul;130(1):1-20
pubmed: 18365233
Mol Biol Cell. 2010 Aug 15;21(16):2944-52
pubmed: 20573978
J Cell Biol. 2007 Jul 30;178(3):517-27
pubmed: 17646397
Mol Biol Cell. 2017 Jan 1;28(1):76-84
pubmed: 27798242
Cell Adh Migr. 2014;8(2):158-64
pubmed: 25422846
Am J Physiol Lung Cell Mol Physiol. 2017 Jun 1;312(6):L1003-L1017
pubmed: 28385807
J Lab Clin Med. 1992 Oct;120(4):513-9
pubmed: 1402326
J Exp Med. 2011 Nov 21;208(12):2393-401
pubmed: 22025303
Annu Rev Pathol. 2011;6:147-63
pubmed: 20936936
Mol Biol Cell. 2006 Sep;17(9):3729-44
pubmed: 16775008
J Biol Chem. 2003 Nov 14;278(46):45117-27
pubmed: 12960176
Proteins. 2006 Jun 1;63(4):1132-6
pubmed: 16534812
Nat Cell Biol. 2008 Aug;10(8):923-34
pubmed: 18604199
Circ Res. 2002 Jul 12;91(1):70-6
pubmed: 12114324
J Clin Invest. 1991 Aug;88(2):531-9
pubmed: 1864964
Methods Mol Biol. 2016;1406:225-37
pubmed: 26820960
Sci Rep. 2019 Mar 5;9(1):3556
pubmed: 30837487
Oncogene. 2007 Feb 15;26(7):1067-77
pubmed: 16909109
Subcell Biochem. 2012;60:197-222
pubmed: 22674073
J Biol Chem. 2015 Apr 10;290(15):9646-59
pubmed: 25681440
Prog Lipid Res. 2012 Apr;51(2):71-81
pubmed: 22212660
Mol Cell Biol. 2014 Jan;34(1):84-95
pubmed: 24164897
Nat Immunol. 2014 Mar;15(3):223-30
pubmed: 24487320
Nature. 2000 Sep 14;407(6801):258-64
pubmed: 11001069
J Biol Chem. 1996 Apr 26;271(17):10334-40
pubmed: 8626603
J Biol Chem. 2000 Feb 25;275(8):5983-6
pubmed: 10681592
Dev Cell. 2012 Jan 17;22(1):146-57
pubmed: 22264731
J Exp Med. 2008 Nov 24;205(12):2929-45
pubmed: 19015309
EMBO J. 2002 Sep 16;21(18):4885-95
pubmed: 12234928
Mol Biol Cell. 2005 Nov;16(11):5141-51
pubmed: 16120645
Blood. 2012 Sep 27;120(13):2745-56
pubmed: 22898603
J Biol Chem. 2014 Feb 21;289(8):5168-83
pubmed: 24352660
Circ Res. 2006 Mar 31;98(6):743-56
pubmed: 16574915
FASEB J. 2019 Jun;33(6):6713-6725
pubmed: 30811216
Dev Cell. 2008 Jan;14(1):25-36
pubmed: 18194650
J Cell Biochem. 2019 Oct;120(10):17723-17730
pubmed: 31168824
Ann N Y Acad Sci. 2008 Mar;1123:134-45
pubmed: 18375586
J Biol Chem. 2014 May 9;289(19):13476-91
pubmed: 24634221
Hepatology. 2000 Jan;31(1):95-100
pubmed: 10613733
J Leukoc Biol. 2018 May;103(5):919-932
pubmed: 29437245

Auteurs

Panfeng Fu (P)

Department of Pharmacology, University of Illinois, Chicago, Illinois.
The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.

Ramaswamy Ramchandran (R)

Department of Pharmacology, University of Illinois, Chicago, Illinois.

Mark Shaaya (M)

Department of Pharmacology, University of Illinois, Chicago, Illinois.

Longshuang Huang (L)

Department of Pharmacology, University of Illinois, Chicago, Illinois.

David L Ebenezer (DL)

Department of Pharmacology, University of Illinois, Chicago, Illinois.

Ying Jiang (Y)

Department of Anesthesiology, University of Illinois, Chicago, Illinois.

Yulia Komarova (Y)

Department of Pharmacology, University of Illinois, Chicago, Illinois.

Stephen M Vogel (SM)

Department of Pharmacology, University of Illinois, Chicago, Illinois.

Asrar B Malik (AB)

Department of Pharmacology, University of Illinois, Chicago, Illinois.

Richard D Minshall (RD)

Department of Pharmacology, University of Illinois, Chicago, Illinois.
Department of Anesthesiology, University of Illinois, Chicago, Illinois.

Guangwei Du (G)

Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, Texas.

Nicholas K Tonks (NK)

Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.

Viswanathan Natarajan (V)

Department of Pharmacology, University of Illinois, Chicago, Illinois visnatar@uic.edu.
Department of Medicine, University of Illinois, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH